CRISPR Therapeutics AG (CRSP)
Biological Products, (No Diagnostic Substances)
Latest Price
$47.99
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
18.89
P/B Ratio
2.54
Valuation metrics
adjust assumptions →Base FCF: $457M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$101.92
+112% upside